Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person8
MACROGENICS INC
Company
ORAGENICS INC
Company
Macy's, Inc.
Company
NEOGENOMICS INC
Company
Inogen Inc
Company
Neurogene Inc.
Company
Maase Inc.
Company
Crocs, Inc.
Company
Primary record7
MACROGENICS INC filed 4
SEC form 4 filed by MACROGENICS INC (CIK 1125345) on 2026-11-03.
MACROGENICS INC filed 4
SEC form 4 filed by MACROGENICS INC (CIK 1125345) on 2026-11-03.
MACROGENICS INC filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 30, 2026, the Board of Directors (the “Board”) of Ma
MACROGENICS INC filed 8-K
Item 8.01 Other Events. On October 23, 2026, MacroGenics, Inc. (the “Company”) issued a press release announcing interim data related to its Phase 1 study evaluating MGC026, a B7-H3-directed antibody-drug conjugate, in p
MACROGENICS INC filed 4
SEC form 4 filed by MACROGENICS INC (CIK 1125345) on 2026-08-20.
ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A
0001172661-26-003604.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001172661-26-002170 0001601086 XXXXXXXX LIVE 8 Common Stock, par value $0.01 per share 06/30/2026 0001125345 MACROGENICS, INC. 55
MACROGENICS INC filed 8-K
Item 2.02 Results of Operations and Financial Condition On August 13, 2026, MacroGenics, Inc. (the "Company") announced financial and operating results as of and for the quarter ended June 30, 2026. The full text of the